| ATROPOS: Survival Analysis of ICI-associated Myocarditis (NCT07633587) | Groupe Hospitalier Pitie-Salpetriere | 2026-05-20 |
| AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis (NCT07644715) | Groupe Hospitalier Pitie-Salpetriere | 2026-01-01 |
| Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension (NCT06515678) | Groupe Hospitalier Pitie-Salpetriere | 2024-05-20 |
| EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database (NCT05934214) | Groupe Hospitalier Pitie-Salpetriere | 2023-01-01 |
| Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients (NCT05819736) | Groupe Hospitalier Pitie-Salpetriere | 2022-12-01 |
| COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival (NCT07729241) | Groupe Hospitalier Pitie-Salpetriere | 2020-12-28 |
| Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 (NCT04320017) | Groupe Hospitalier Pitie-Salpetriere | 2020-03-20 |
| Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (NCT04314817) | Groupe Hospitalier Pitie-Salpetriere | 2020-03-17 |
| Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study (NCT04365764) | Groupe Hospitalier Pitie-Salpetriere | 2020-03-14 |
| Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis (NCT04426747) | Groupe Hospitalier Pitie-Salpetriere | 2019-09-01 |
| Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) (NCT03994302) | Groupe Hospitalier Pitie-Salpetriere | 2019-06-01 |
| Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) (NCT03947034) | Groupe Hospitalier Pitie-Salpetriere | 2019-05-01 |
| Monitoring Drug-induced Myocarditis (CardiTOX) (NCT03855982) | Groupe Hospitalier Pitie-Salpetriere | 2019-04-09 |
| Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care (NCT03882580) | Groupe Hospitalier Pitie-Salpetriere | 2019-03-01 |
| Monitoring the HeMAtological TOXicity of Drugs (HeMATOX) (NCT03828942) | Groupe Hospitalier Pitie-Salpetriere | 2019-02-01 |
| JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors (NCT04294771) | Groupe Hospitalier Pitie-Salpetriere | 2019-01-01 |
| a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY (NCT04290611) | Groupe Hospitalier Pitie-Salpetriere | 2019-01-01 |
| Monitoring the IMmUological TOXicity of Drugs (NCT03480529) | Groupe Hospitalier Pitie-Salpetriere | 2018-03-01 |
| Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction (NCT03492242) | Groupe Hospitalier Pitie-Salpetriere | 2018-02-01 |
| Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors Associated Cardiovascular Adverse reactioN. (NCT03413176) | Groupe Hospitalier Pitie-Salpetriere | 2018-01-01 |
| Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions (NCT03387540) | Groupe Hospitalier Pitie-Salpetriere | 2017-12-02 |
| PheWAS of a Polygenic Predictor of Thyroid Function (NCT03597659) | Groupe Hospitalier Pitie-Salpetriere | 2017-09-01 |